People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Saluda Medical, Inc. | — | Healthtech | Series D+ | $180.0M | $232.4M | 2023 |
James Schuermann at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Schuermann on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Andrew Cleeland | 1 | 5 |
| Juan-Pablo Mas | 1 | 5 |
| Doug Godshall | 1 | 3 |
| Robert Palmisano | 1 | 3 |
| Robert Faulkner | 1 | 2 |
| Geoffrey Brooke | 1 | 2 |
| Catherine Livingstone | 1 | 2 |
| Chris Beare | 1 | 1 |
| Geoffrey Kinghorn | 1 | 1 |
| Kristin Caplice | 1 | 1 |
| Greg Plamondon | 1 | 1 |
| Laureen DeBuono | 1 | 1 |
| Barry Regan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.